Related Experiment Videos
Induction of prophage lambda by daunorubicin and derivatives correlation with antineoplastic activity
Mutation Research
|March 1, 1980
Summary
Daunorubicin and other anthracyclines damage bacterial DNA, leading to prophage lambda induction. This DNA damage mechanism correlates with their anticancer potency, suggesting a shared pathway for both effects.
Area of Science:
- Molecular Biology
- Microbiology
- Pharmacology
Background:
- Daunorubicin is an antineoplastic drug.
- Anthracyclines are a class of compounds with antineoplastic properties.
- Prophage induction is a response to DNA damage in bacteria.
Purpose of the Study:
- To investigate the DNA-damaging capacity of daunorubicin and related anthracyclines.
- To determine if DNA damage correlates with antineoplastic activity.
- To explore the role of bacterial enzymes and DNA repair mechanisms in anthracycline-induced prophage induction.
Main Methods:
- Testing daunorubicin and 15 other anthracyclines for prophage lambda induction in Escherichia coli K12.
- Comparing induction in excision-repair deficient (uvr-) and proficient (uvr+) bacterial strains.
- Conducting a blind test to compare antineoplastic and prophage-inducing potencies.
Main Results:
- Daunorubicin induced prophage lambda at lower doses in uvr- bacteria, indicating DNA lesions are subject to excision repair.
- Bacterial enzymes appear to convert daunorubicin into active DNA-damaging species.
- A correlation was observed between antineoplastic and prophage-inducing potencies for two-thirds of the tested anthracyclines.
Conclusions:
- Anthracyclines induce DNA damage, leading to prophage lambda induction in bacteria.
- Excision repair mechanisms can mitigate some DNA lesions caused by daunorubicin.
- The correlation between DNA damage and antineoplastic activity supports the hypothesis that DNA damage is a key mechanism of anthracycline anticancer effects.